BIOMAT Database Logo BIOMAT Database Logo

2-amino-4H-3,1-benzoxazin-4-ones as inhibitors of C1r serine protease. 1998

S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Department of Chemistry, Parke-Davis Pharmaceutical Research, Division of Warner-Lambert Company, Ann Arbor, Michigan 48105, USA.

A series of 2-amino-4H-3,1-benzoxazin-4-ones have been synthesized and evaluated as inhibitors of the complement enzyme C1r. C1r is a serine protease at the beginning of the complement cascade, and complement activation by beta-amyloid may represent a major contributing pathway to the neuropathology of Alzheimer's disease. Compounds such as 7-chloro-2-[(2-iodophenyl)-amino]benz[d][1,3]oxazin-4-one (32) and 7-methyl-2-[(2-iodophenyl)amino]benz[d][1,3]oxazin-4-one (37) show improved potency compared to the reference compound FUT-175. Many of these active compounds also possess increased selectivity for C1r compared to trypsin and enhanced hydrolytic stability relative to 2-(2-iodophenyl)-4H-3,1-benzoxazin-4-one (1).

UI MeSH Term Description Entries
D010078 Oxazines Six-membered heterocycles containing an oxygen and a nitrogen.
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D014361 Trypsin Inhibitors Serine proteinase inhibitors which inhibit trypsin. They may be endogenous or exogenous compounds. Trypsin Inhibitor,Inhibitor, Trypsin,Inhibitors, Trypsin
D015842 Serine Proteinase Inhibitors Exogenous or endogenous compounds which inhibit SERINE ENDOPEPTIDASES. Serine Endopeptidase Inhibitor,Serine Endopeptidase Inhibitors,Serine Protease Inhibitor,Serine Protease Inhibitors,Serine Proteinase Antagonist,Serine Proteinase Antagonists,Serine Proteinase Inhibitor,Serine Proteinase Inhibitors, Endogenous,Serine Proteinase Inhibitors, Exogenous,Serine Protease Inhibitors, Endogenous,Serine Protease Inhibitors, Exogenous,Antagonist, Serine Proteinase,Endopeptidase Inhibitor, Serine,Inhibitor, Serine Endopeptidase,Inhibitor, Serine Protease,Inhibitor, Serine Proteinase,Protease Inhibitor, Serine,Proteinase Antagonist, Serine,Proteinase Inhibitor, Serine
D015923 Complement C1r A 80-kDa subcomponent of complement C1, existing as a SERINE PROTEASE proenzyme in the intact complement C1 complex. When COMPLEMENT C1Q is bound to antibodies, the changed tertiary structure causes autolytic activation of complement C1r which is cleaved into two chains, A (heavy) and B (light, the serine protease), connected by disulfide bonds. The activated C1r serine protease, in turn, activates COMPLEMENT C1S proenzyme by cleaving the Arg426-Ile427 bond. No fragment is released when either C1r or C1s is cleaved. C1r Complement,Complement 1r,Complement Component 1r,C1r, Complement,Complement, C1r,Component 1r, Complement

Related Publications

S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Studies on 2-benzyloxy-4H-3,1-benzoxazin-4-ones as serine protease inhibitors.
July 1998, Pharmaceutica acta Helvetiae,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Benzenesulfonamide derivatives of 2-substituted 4H-3,1-benzoxazin-4-ones and benzthiazin-4-ones as inhibitors of complement C1r protease.
March 1999, Bioorganic & medicinal chemistry letters,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Structure-activity studies on 2-aryl-4H-3,1-benzoxazin-4-ones.
October 1994, Anti-cancer drugs,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Inhibition of cathepsin G by 4H-3,1-benzoxazin-4-ones.
October 1997, Bioorganic & medicinal chemistry,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
2-Phenyl-4H-3,1-benzoxazin-4-one.
December 2008, Acta crystallographica. Section E, Structure reports online,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Inhibition of human chymase by 2-amino-3,1-benzoxazin-4-ones.
April 2001, Bioorganic & medicinal chemistry,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
2-(2-Amino-4-nitro-phen-yl)-7-nitro-4H-3,1-benzoxazin-4-one.
February 2014, Acta crystallographica. Section E, Structure reports online,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Inhibition of chymotrypsin and pancreatic elastase by 4H-3,1-benzoxazin-4-ones.
January 1991, Journal of enzyme inhibition,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Design and synthesis of 4H-3,1-benzoxazin-4-ones as potent alternate substrate inhibitors of human leukocyte elastase.
February 1990, Journal of medicinal chemistry,
S J Hays, and B W Caprathe, and J L Gilmore, and N Amin, and M R Emmerling, and W Michael, and R Nadimpalli, and R Nath, and K J Raser, and D Stafford, and D Watson, and K Wang, and J C Jaen
Facile synthesis and herbicidal evaluation of 4H-3,1-benzoxazin-4-ones and 3H-quinazolin-4-ones with 2-phenoxymethyl substituents.
March 2012, Molecules (Basel, Switzerland),
Copied contents to your clipboard!